Dollar Dominates as Rotation Deepens: Healthcare and Industrials Take the Lead

Market Regime

The VIX settled at 18.63, edging down from last week's mid-19s but still above the Goldilocks lows of early June. The 10-year yield fell 9bp to 4.41%, flattening the curve to +30bp — a signal that growth expectations are moderating. The real story this week is the US Dollar: the Broad USD Index climbed to 120.40, up another 0.8% in a week, crushing commodities across the board (gold -10.8%, silver -24.9%, WTI -20.2% over 1 month). Sticky CPI stayed elevated at 3.09%, keeping the Fed's 'optionality' alive.

Mega Forces

1. Dollar Strength & Commodity Takedown — A stronger dollar is disinflationary for raw materials but creates headwinds for commodity producers and commodity-exporting EMs. Brazil (-5.4%), China (-8.9%), and Hong Kong (-8.0%) are suffering. The flip side: US asset deflation in real terms means hard assets are underperforming while US-centric sectors thrive.
2. Healthcare Renaissance — The standout rotation of June: Healthcare sector +5.3% in the past month, with biotech (+13.8% via XBI), genomics (+28.1% ARKG), and CROs (+29.5% theme) leading. Kymera's eczema trial enrollment six months early (KYMR +16.6%) and the Merck KGaA acquisition of Bio-Techne (TECH +20%) confirm institutional interest in life sciences tools and novel therapeutics.
3. AI Infrastructure Matures: From Chips to Deployment — The AI narrative is shifting from GPU scarcity to real-world buildout. CoreWeave's $335M storage deal with BLZE (+44%), HIVE Digital's 10-year lease for an AI data center, and Qualcomm's $15B data center revenue target with Meta/Microsoft as clients all point to a broadening opportunity beyond the semiconductor foundry.
4. Earnings-Driven Rotation — Q2 results are rewarding discipline: AYI (lighting, +17.6%) and MEI (+37.5%) beat estimates on strong operations, while Apple's price hikes confirm memory cost pressure is real. Companies with pricing power and operational leverage are separating from the pack.

What's Working

• US Industrials (+5.9% in 1 month): Specialty & heavy vehicle manufacturing (+32.9% theme), motion & fluid control (+23.4%). AYI's AIS segment growth validates automation capex.
• Healthcare/Biotech: CROs, medical imaging, precision oncology, biopharma platforms — all up 20%+. The sector now offers both defensive qualities and growth optionality.
• International: Korea & Taiwan — Up +2.2% and +2.7% respectively despite dollar headwinds, driven by structural AI demand.
• Airlines (JETS +16.7%): Strong demand and lower fuel costs are lifting the sector.

What to Avoid

The dollar's rising tide is sinking commodities (gold, silver, oil), crypto/digital assets (-32.3% theme), and space/satellite (-34.6%). Consumer Discretionary (-4.9%) and Communication Services (-8.4%) lag as Apple's price hikes and margin fears pressure the mega-cap growth names. Solar and aluminum continue their sharp declines.

Strategy

Position for a regime defined by dollar strength and a broadening AI deployment cycle. Favor US healthcare and industrials with demonstrated earnings momentum. Add exposure to Korea and Taiwan through thematic ETFs for the AI supply chain. Avoid commodity producers and early-stage space/crypto moonshots. The next leg of the market will be won by execution, not hype.